532 related articles for article (PubMed ID: 16456490)
1. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
[TBL] [Abstract][Full Text] [Related]
2. Severe hyponatremia due to desmopressin.
Kelleher HB; Henderson SO
J Emerg Med; 2006 Jan; 30(1):45-7. PubMed ID: 16434334
[TBL] [Abstract][Full Text] [Related]
3. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
Arima H; Oiso Y; Juul KV; Nørgaard JP
Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
[TBL] [Abstract][Full Text] [Related]
5. Severe water intoxication secondary to the concomitant intake of non-steroidal anti-inflammatory drugs and desmopressin: a case report and review of the literature.
Verrua E; Mantovani G; Ferrante E; Noto A; Sala E; Malchiodi E; Iapichino G; Peccoz PB; Spada A
Hormones (Athens); 2013; 12(1):135-41. PubMed ID: 23624139
[TBL] [Abstract][Full Text] [Related]
6. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
7. Comments on "Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study"--efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus.
Kamoi K
Endocr J; 2013; 60(9):1115. PubMed ID: 23863202
[No Abstract] [Full Text] [Related]
8. Management of central diabetes insipidus with oral desmopressin in a patient with ectrodactyly and cleft lip/palate (ECP) syndrome.
Ozaydin E; Aycan Z; Yusufoğlu AM; Cetinkaya E; Ergen S; Unal S; Köse G
Turk J Pediatr; 2009; 51(1):89-93. PubMed ID: 19378901
[TBL] [Abstract][Full Text] [Related]
9. Trauma-induced central diabetes insipidus in a cat.
Campbell FE; Bredhauer B
Aust Vet J; 2008 Mar; 86(3):102-5. PubMed ID: 18304048
[TBL] [Abstract][Full Text] [Related]
10. Diabetes insipidus: clinical and basic aspects.
Majzoub JA; Srivatsa A
Pediatr Endocrinol Rev; 2006 Dec; 4 Suppl 1():60-5. PubMed ID: 17261971
[TBL] [Abstract][Full Text] [Related]
11. Treatment of central diabetes insipidus in adults and children with desmopressin.
Ziai F; Walter R; Rosenthal IM
Arch Intern Med; 1978 Sep; 138(9):1382-5. PubMed ID: 686929
[TBL] [Abstract][Full Text] [Related]
12. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
Robson WL; Leung AK; Norgaard JP
J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054
[TBL] [Abstract][Full Text] [Related]
13. Use of subcutaneous DDAVP in infants with central diabetes insipidus.
Blanco EJ; Lane AH; Aijaz N; Blumberg D; Wilson TA
J Pediatr Endocrinol Metab; 2006 Jul; 19(7):919-25. PubMed ID: 16995572
[TBL] [Abstract][Full Text] [Related]
14. [Treatment with sublingual desmopressin in two infants with hydranencephaly and central diabetes insipidus].
Marín GR; Baspineiro B; Vilca I
Arch Argent Pediatr; 2018 Feb; 116(1):e93-e97. PubMed ID: 29333830
[TBL] [Abstract][Full Text] [Related]
15. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
Almutlaq N; Eugster EA
J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
[TBL] [Abstract][Full Text] [Related]
16. [Persistent central diabetes insipidus in a very low birth weight infant].
Quetin F; Garnier H; Brauner R; Vodovar M; Magny JF
Arch Pediatr; 2007 Nov; 14(11):1321-3. PubMed ID: 17916426
[TBL] [Abstract][Full Text] [Related]
17. Short-term stimulation of the thiazide-sensitive Na+-Cl- cotransporter by vasopressin involves phosphorylation and membrane translocation.
Mutig K; Saritas T; Uchida S; Kahl T; Borowski T; Paliege A; Böhlick A; Bleich M; Shan Q; Bachmann S
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F502-9. PubMed ID: 20007345
[TBL] [Abstract][Full Text] [Related]
18. [A case of sarcoidosis with diabetes insipidus].
Sugiyama K; Mukae H; Sakamoto N; Iwata A; Amenomori M; Ishimoto H; Miyazaki H; Hisatomi K; Ishii H; Nakayama S; Ishimatsu Y; Kohno S
Nihon Kokyuki Gakkai Zasshi; 2007 Jan; 45(1):105-9. PubMed ID: 17313038
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin for diabetes insipidus, hemostatic disorders and enuresis.
Shulman LH; Miller JL; Rose LI
Am Fam Physician; 1990 Oct; 42(4):1051-7. PubMed ID: 2220513
[TBL] [Abstract][Full Text] [Related]
20. DDAVP in the treatment of central diabetes insipidus.
Robinson AG
N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
